Archives

Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion

B FDA authorization marks critical milestone enabling advancement of next-generation bone regeneration therapy for patients with degenerative spinal diseases FREDERICK, Md., April 30, 2026 /PRNewswire/… Login to continue reading Login…

Read MoreTheradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion

Brand Engagement Network (NASDAQ: BNAI) Signs Definitive Agreement to Acquire Cataneo GmbH, a Global Media Infrastructure Leader, in a Debt-Free $19.5 Million Transaction

B Combined Collaboration and Patented AI Technology to Power 1:1 Engagement Across Ad-Driven Systems WILMINGTON, Del. and MUNICH, April 30, 2026 /PRNewswire/ — Brand Engagement… Login to continue reading Login…

Read MoreBrand Engagement Network (NASDAQ: BNAI) Signs Definitive Agreement to Acquire Cataneo GmbH, a Global Media Infrastructure Leader, in a Debt-Free $19.5 Million Transaction